Nirvana Life Sciences Inc.
NIRVF
$0.0083
$0.000.00%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -94.20% | -93.65% | -84.78% | -28.13% | 64.29% |
| Total Receivables | -23.60% | -21.26% | 10.57% | 36.63% | 89.36% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -73.12% | -85.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -68.54% | -77.57% | -70.36% | -58.97% | -71.10% |
|
|
|||||
| Total Current Assets | -68.54% | -77.57% | -70.36% | -58.97% | -71.10% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 215.73% | -77.57% | -70.36% | -46.27% | -88.02% |
|
|
|||||
| Total Accounts Payable | 7.75% | 24.17% | 6.64% | -31.67% | -10.46% |
| Total Accrued Expenses | 38.90% | 36.75% | 19.83% | 35.45% | 21.99% |
| Short-term Debt | 217.95% | 298.36% | -52.20% | -71.59% | -64.38% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 0.00% | -3.85% | -1.96% | 0.00% | -1.96% |
| Total Other Current Liabilities | 0.00% | -3.85% | -1.96% | 0.00% | -1.96% |
| Total Current Liabilities | 38.01% | 36.74% | 13.31% | 8.97% | 9.34% |
|
|
|||||
| Total Current Liabilities | 38.01% | 36.74% | 13.31% | 8.97% | 9.34% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 217.95% | 298.36% | -52.20% | -71.59% | -64.38% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 57.04% | 36.98% | 13.31% | 8.97% | 9.34% |
|
|
|||||
| Common Stock & APIC | -0.33% | -4.77% | 7.07% | 8.17% | 6.54% |
| Retained Earnings | -5.21% | -1.89% | -9.78% | -17.07% | -19.36% |
| Treasury Stock & Other | 13.51% | 23.24% | 29.36% | 372.09% | 340.58% |
| Total Common Equity | -45.63% | -51.18% | -19.32% | -48.13% | -165.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -45.63% | -51.18% | -19.32% | -48.13% | -165.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -25.81% | -23.33% | -44.00% | -250.00% | -1,133.33% |
| Total Equity | -45.53% | -51.03% | -19.42% | -48.59% | -167.41% |
|
|
|||||
